Now showing items 1-6 of 6
Mesenchymal Stem Cells (MSCs) and cancer: tumour specific delivery vehicles or therapeutic targets?
(Mary Ann Liebert, 2010-09-30)
Mesenchymal stem cells (MSCs) are a subset of nonhematopoietic multipotent cells found primarily within the bone marrow stroma. The ability of MSCs to specifically home to sites of tumors and their metastases, while escaping ...
Myeloma: making sense of a complex blood cancer
(Mark Allen Healthcare, 2010)
Myeloma is a challenging blood cancer characterized by bone destruction, hypercalcaemia, renal insufficiency and anaemia. Although myeloma remains incurable, recent advancements in treatments have resulted in significant ...
Patients’ lived experience of myeloma
(RCN Publishing, 2011-03-16)
Aim To explore patients’ lived experience of being diagnosed with myeloma. Method A hermeneutic phenomenological approach was adopted to analyse data from interviews with 11 patients diagnosed with myeloma. Findi ...
Lymphoma survivors' experiences at the end of treatment
Aims and Objectives To explore lymphoma survivors’ experiences on their end of treatment and follow‐up care at a large urban haematology centre in Ireland. Methods This was a qualitative study using semistructured ...
Survivorship care for postmenopausal breast cancer patients in Ireland: What do women want?
Purpose: The aim of this study was to identify the concerns of postmenopausal breast cancer patients in Ireland and inform the development of a survivorship care plan.Method: A qualitative participatory approach was used. ...
Vitamin D supplementation and clinical outcomes in cancer survivorship
(Mark Allen Healthcare, 2018-10-22)
Increasing evidence points to the role of vitamin D supplementation in cancer management. A comprehensive search of online databases was undertaken for all research studies relating to vitamin D supplementation in cancer ...